川崎病
全基因组关联研究
基因分型
冠状动脉疾病
医学
动脉瘤
血管炎
冠状动脉
基因
冠状动脉瘤
遗传关联
生物信息学
内科学
病理
遗传学
疾病
动脉
生物
单核苷酸多态性
基因型
外科
作者
Ho‐Chang Kuo,Sung‐Chou Li,Mindy Ming‐Huey Guo,Ying‐Hsien Huang,Hong‐Ren Yu,Fu‐Chen Huang,Fuyong Jiao,Hsing‐Chun Kuo,Jorge Andrade,Wen‐Ching Chan
出处
期刊:PLOS ONE
[Public Library of Science]
日期:2016-05-12
卷期号:11 (5): e0154943-e0154943
被引量:68
标识
DOI:10.1371/journal.pone.0154943
摘要
Kawasaki disease (KD) or Kawasaki syndrome is known as a vasculitis of small to medium-sized vessels, and coronary arteries are predominantly involved in childhood. Generally, 20-25% of untreated with IVIG and 3-5% of treated KD patients have been developed coronary artery lesions (CALs), such as dilatation and aneurysm. Understanding how coronary artery aneurysms (CAAs) are established and maintained in KD patients is therefore of great importance. Upon our previous genotyping data of 157 valid KD subjects, a genome-wide association study (GWAS) has been conducted among 11 (7%) CAA-developed KD patients to reveal five significant genetic variants passed pre-defined thresholds and resulted in two novel susceptibility protein-coding genes, which are NEBL (rs16921209 (P = 7.44 × 10(-9); OR = 32.22) and rs7922552 (P = 8.43 × 10(-9); OR = 32.0)) and TUBA3C (rs17076896 (P = 8.04 × 10(-9); OR = 21.03)). Their known functions have been reported to associate with cardiac muscle and tubulin, respectively. As a result, this might imply their putative roles of establishing CAAs during KD progression. Additionally, various model analyses have been utilized to determine dominant and recessive inheritance patterns of identified susceptibility mutations. Finally, all susceptibility genes hit by significant genetic variants were further investigated and the top three representative gene-ontology (GO) clusters were regulation of cell projection organization, neuron recognition, and peptidyl-threonine phosphorylation. Our results help to depict the potential routes of the pathogenesis of CAAs in KD patients and will facilitate researchers to improve the diagnosis and prognosis of KD in personalized medicine.
科研通智能强力驱动
Strongly Powered by AbleSci AI